Natixis Advisors’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.03M	Sell	25,634 -10,753	-30%	-$402K	﹤0.01%	1346
2025 Q4	$1.27M	Sell	36,387 -5,701	-14%	-$448K	﹤0.01%	1188
2025 Q3	$3.5M	Sell	42,088 -68	-0.2%	-$4.92K	0.01%	943
2025 Q2	$3.09M	Buy	42,156 +2,426	+6%	+$176K	﹤0.01%	965
2025 Q1	$4.54M	Buy	39,730 +7,607	+24%	+$463K	0.01%	839
2024 Q4	$1.62M	Buy	32,123 +3,979	+14%	+$208K	﹤0.01%	1165
2024 Q3	$1.3M	Buy	28,144 +7,484	+36%	+$266K	﹤0.01%	1222
2024 Q2	$671K	Buy	20,660 +2,854	+16%	+$78.2K	﹤0.01%	1367
2024 Q1	$449K	Sell	17,806 -4,101	-19%	-$96.9K	﹤0.01%	1418
2023 Q4	$711K	Sell	21,907 -1,886	-8%	-$51.8K	﹤0.01%	1312
2023 Q3	$648K	Buy	23,793 +4,921	+26%	+$142K	﹤0.01%	1294
2023 Q2	$420K	Sell	18,872 -1,615	-8%	-$37.2K	﹤0.01%	1372
2023 Q1	$444K	Buy	20,487 +5,710	+39%	+$125K	﹤0.01%	1337
2022 Q4	$300K	Sell	14,777 -4,123	-22%	-$103K	﹤0.01%	1392
2022 Q3	$485K	Buy	18,900 +2,400	+15%	+$64.2K	﹤0.01%	1293
2022 Q2	$392K	Sell	16,500 -2,081	-11%	-$45.3K	﹤0.01%	1331
2022 Q1	$418K	Buy	18,581 +6,726	+57%	+$143K	﹤0.01%	1319
2021 Q4	$235K	Buy	+11,855	New	+$240K	﹤0.01%	1339